Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Wayne M. Turner
Observed names:
W M Turner,
WAYNE M. TURNER,
Wayne Turner
Institution:
United States Food and Drug Administration
Observed institution:
United States Food and Drug Administration
OpenAlex ID:
A5043614871
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study
2018
·
Paresh Dandona
, Chantal Mathieu
, et al.
·
Diabetes Care
·
260
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis
2021
·
Zien Zhou
, Meg J. Jardine
, et al.
·
Stroke
·
134
PDF
Patterns of oral anticoagulant use and outcomes in Asian patients with atrial fibrillation: a post-hoc analysis from the GLORIA-AF Registry
2023
·
Giulio Francesco Romiti
, Bernadette Corica
, et al.
·
EClinicalMedicine
·
49
PDF
The Food and Drug Administration Algorithm: Special Workshop—Regulatory
1984
·
Wayne M. Turner
·
Drug Information Journal
·
40
Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial
2023
·
Tae Won Yi
, Brendan Smyth
, et al.
·
American Journal of Kidney Diseases
·
37
PDF
Lidocaine and Psychotic Reactions
1982
·
WAYNE M. TURNER
·
Annals of Internal Medicine
·
27
Lidocaine-Propranolol Interactions
1981
·
C F Graham
, W M Turner
, et al.
·
New England Journal of Medicine
·
24
Postmarketing Reporting of Adverse Drug Reactions to the FDA: An Overview of the 1985 FDA Guideline
1986
·
Judith M. Sills
, Gerald A. Faich
, et al.
·
Drug Information Journal
·
23
Food and Drug Administration's Adverse Drug Reaction Monitoring Program
1978
·
Beulah Lee
, Wayne M. Turner
·
American Journal of Health-System Pharmacy
·
14
The Processing of Adverse Reaction Reports at FDA
1986
·
Wayne M. Turner
, Julie B. Milstien
, et al.
·
Drug Information Journal
·
12
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
2023
·
Wern Yew Ding
, Ameenathul Mazaya Fawzy
, et al.
·
Journal of Thrombosis and Thrombolysis
·
8
FDA Processing of ADR Reports
1985
·
Wayne M. Turner
·
Drug Information Journal
·
2
A Microcomputer-Based Data Entry System for Reporting Adverse Drug Reactions in the United States
1988
·
Michael H. Dong
, Charles Anello
, et al.
·
Drug Information Journal
·
1
PDF
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
2022
·
Gregory Y. H. Lip
, Agnieszka Kotalczyk
, et al.
·
Clinical Research in Cardiology
PDF
Show more works
View as search
Works count:
14
Citation count:
631
H-index:
10
I10-index:
10
Year
Topic
Type